Dr Shaila Angela Lewis
Professor and Head
Date of Joining : 08.11.2002
Department of Pharmaceutics
CURRENT ACADEMIC ROLE & RESPONSIBILITIES
Dr Shaila Lewis is involved in teaching under graduates(UG), post graduates (PG), supervising post graduate dissertation and guiding PhD students.
?
SUBJECTS CURRENTLY TEACHING
| Subject | Semester / Year |
|---|---|
| Industrial Pharmacy I (Theory) | BPharm Sem-V |
| Industrial Pharmacy I (Practical) | BPharm Sem-V |
| Drug Delivery Systems | MPharm Pharmaceutics Sem I |
| Pharmaceutics Practical I | MPharm Pharmaceutics Sem I |
| Molecular Pharmaceutics (Nano Tech and Targeted DDS) | MPharm Pharmaceutics Sem II |
| Pharmaceutics Practical II | MPharm Pharmaceutics Sem II |
ACADEMIC QUALIFICATIONS
| Degree | Specialisation | Institute | Year of passing |
|---|---|---|---|
| PhD | Pharmaceutical Sciences | MCOPS, 沙巴体育 | |
| MPharm | Pharmaceutics | MCOPS, 沙巴体育 | |
| BPharm | Pharmacy | MCOPS, 沙巴体育 | 1994 |
Experience
| Institution / Organisation | Designation | Role | Tenure |
|---|---|---|---|
| MCOPS, 沙巴体育 | Professor | 2021 to till date | |
| MCOPS, 沙巴体育 | Associate Professor - Senior Scale | 2017-2021 | |
| MCOPS, 沙巴体育 | Associate Professor | Oct 2008 to 2017 | |
| MCOPS, 沙巴体育 | Assistant Professor | Feb 2004 to Sep 2008 | |
| MCOPS, 沙巴体育 | Lecturer | Nov 2002 to Jan 2004 |
Formulation and Evaluation of lacidipine nano drug delivery systems
Funded by All India Council for Technical Education, New Delhi, India
AREAS OF INTEREST, EXPERTISE AND RESEARCH
Area of Interest
Novel drug delivery
Area of Expertise
Nanoparticulate drug delivery, Formulation development
Area of 沙巴体育
Solid lipid nanoparticles Chitosan Derivatives for drug delivery Bioavailability enhancement techniques
Professional Affiliations & Contributions
Current memberships in professional societies and chapters:
- Indian Pharmaceutical Association
- Association of Pharmaceutical teachers of India
Work Experience
| Organisation | Role | Tenure |
|---|---|---|
| Cipla Ltd., Mumbai | Formulation Development Officer – Formulation development of various dosage forms (tablets, capsules, suspensions, semisolids)for local as well as overseas market) |
Full publication list can be viewed at?
https://manipal.pure.elsevier.com/en/persons/shaila-a-lewis
https://eprints.manipal.edu/view/creators/Lewis=3AShaila_Angela=3A=3A.html
Enhancement of Aqueous Solubility and Oral Bioavailability of Nelfinavir by Complexation with ?-Cyclodextrin
Shilpi Kumari Bhawar G.T. Musmade P.
Trop J. Pharm. Res., 14(8):1333-1340 (2015).
Development and Validation of a Reverse Phase HPLC Method for the Estimation of Lacidipine in Nanoformulations
Shirodkar, R.K. Shetty P. Kumar L. Mutalik S.
Lat. Am. J. Pharm. 34 (6): 1162-1166. (2015)
Subacute Toxicity Profile of Lacidipine Nanoformulation in Wistar Rats
Shirodkar, R.K. Misra C. Chethan G.H. Shetty P. Attari Z. Mutalik S.
The Scientific World Journal. Volume 2015. Article ID 947623.
Development and Validation of a Reverse Phase HPLC Method for the estimation of lacidipine in rat plasma: Application to preclinical Pharmacokinetics
Shirodkar R.K. Kumar L. Misra C. Managuli R. Attari Z. Mutalik S.
Lat Am. J. Pharm. 35(1):124-29 (2016).
Development and validation of a reverse phase HPLC method for the estimation of Lacidipine in rat plasma:application to preclinical pharmacokinetics
Rupesh K Shirodkar Lalit Kumar Chandrashekar Misra Renuka Managuli Zenab Attari
Lat. Am. J Pharm. 2016, 35(1): 124-129.
Enhanced ex vivo intestinal absorption of olmesartan medoxomil nanosuspension: preparation by combinative technology
Zenab Attari Amita Bhandari PC Jagadish
Saudi Pharm J. 2016, 24: 57-63
Characterization and in vivo evaluation of lacidipine inclusion complexes with β-cyclodextrin and its derivatives
T Darekar K S Aithal R Shirdkar L Kumar
J Incl Phenom Macrocyl Chem. 2016, 84: 225-235
Acyclovir entrapped N-trimethyl chitosan nanoparticles for oral bioavailability enhancement
Ushasree Medikonduri Zenab Attari Krishnamurthy Bhat
Cur. Nanosci. 2016, 12: 378-385.
Mucoadhesive Buccal Composition containing nicotine useful for smoking cessation and a process for its preparation
Indian Patent No 221428 (968/CHE/2004) granted on 23.06.2008
Enhancement of Bioavailability of Acyclovir using N,N,N-Trimethyl Chitosan Chloride
UshaSree Medikonduri
PG Project (2013)
Enhancement of Bioavailability of Felodipine
Amita Bhandari
PG Project (2014)
Formulation and Evaluation of Lamotrigine Extended Release Tablets
B Sunil
PG Project (2014)
Formulation Development and Evaluation of Push Pull Osmotic Bilayer Tablet of Beta 1- Adrenoreceptor Blocking Agent
Prabhudessai Sayalee Padmanabh
PG Project (2015)
Formulation and Evaluation of Oral Disintegrating Tablet
KM Raksha Gupta
PG Project (2015)
Formulation Development of Dispersible Tablets of Combinational Anti-Retroviral Drugs
Shabana
PG Project (2015)
Study of The Inclusion Complex of Telmisartan With Sulfobutyl Ether Beta-Cyclodextrin
Abhishek Chandra
PG project (2016)
Formulation And Developoment Of Antidepressant Hard Gelatin Capsules
Jessica Gomes
PG project
Formulation of Immediate Release Tablets of Loperamide Hydrochloride And Simethicone
Sunkara Deepthi
PG project (2016)